Latest News about APLS
Recent news which mentions APLS
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 20, 2023
From Benzinga
Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target
July 20, 2023
Tickers
APLS
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
From Benzinga
From Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
From Benzinga
From Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
From Benzinga
From Benzinga
From Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
From Benzinga
From InvestorPlace
Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
May 25, 2023
From Benzinga
Why Shares of Annexon Are Plummeting Thursday
May 25, 2023
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
From MarketWatch
Apellis Pharma's Newly Approved Drug Exceeds Sales Projections, Bullish Analyst Raises Expectations
May 05, 2023
Tickers
APLS
From Benzinga
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
May 01, 2023
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 26, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
From Benzinga
Wedbush Maintains Neutral Rating for Apellis Pharmaceuticals: Here's What You Need To Know
April 17, 2023
Tickers
APLS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
